Mark Shelton
Impact in
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- Parvovirus B19 Infection Studies
- Antifungal resistance and susceptibility
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 27
- HIV/AIDS Research and Interventions 7
- Epidemiology 22
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Cytomegalovirus and herpesvirus research 6
- Co-authors
- Richard J. Whitley (7 shared papers)Richard F. Jacobs (6 shared papers)David W. Kimberlin (6 shared papers)Gene D. Morse (20 shared papers)Robert F. Pass (4 shared papers)Gail J. Demmler (4 shared papers)Pablo J. Sánchez (3 shared papers)Chin‐Yu Lin (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (15 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (7 papers)The Journal of Clinical Pharmacology (3 papers)Clinical Pharmacokinetics (3 papers)Journal of Viral Hepatitis (2 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Mark Shelton
60 papers receiving 2.6k citations
Mark Shelton's Hit Papers
Peers
Comparison fields: 5 of 106
- Infectious Diseases 1.0k
- Epidemiology 1.7k
- Hepatology 303
- Virology 181
- Pediatrics, Perinatology and Child Health 292
Countries citing papers authored by Mark Shelton
This map shows the geographic impact of Mark Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shelton more than expected).
Fields of papers citing papers by Mark Shelton
This network shows the impact of papers produced by Mark Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shelton. The network helps show where Mark Shelton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shelton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial Hit paper breakdown → | 2003 | 621 |
| 2 | 2001 | 313 | |
| 3 | 1998 | 188 | |
| 4 | 2009 | 176 | |
| 5 | 1991 | 170 | |
| 6 | 1993 | 100 | |
| 7 | 2006 | 93 | |
| 8 | 2005 | 86 | |
| 9 | 2015 | 75 | |
| 10 | 2003 | 70 | |
| 11 | 1990 | 65 | |
| 12 | 2021 | 54 | |
| 13 | 2000 | 51 | |
| 14 | 1996 | 44 | |
| 15 | 2001 | 40 | |
| 16 | 1992 | 34 | |
| 17 | 2010 | 32 | |
| 18 | 1997 | 32 | |
| 19 | 2011 | 27 | |
| 20 | 2006 | 26 |
About Mark Shelton
Mark Shelton is a scholar working on Infectious Diseases, Epidemiology, Virology, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 63 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Cytomegalovirus and herpesvirus research (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), HIV-related health complications and treatments (5 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Epidemiology (1.7k citations), Hepatology (303 citations), Virology (181 citations) and Pediatrics, Perinatology and Child Health (292 citations). Mark Shelton has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Richard J. Whitley, Richard F. Jacobs, David W. Kimberlin, Gene D. Morse, Robert F. Pass, Gail J. Demmler, Pablo J. Sánchez, Chin‐Yu Lin, Wendy Vaudry and Wayne M. Dankner. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, The Journal of Clinical Pharmacology, Clinical Pharmacokinetics and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.